绥美凯说明书

It is a three-in-one compound drug containing dolutegravir (DTG) that was approved for marketing in the United States in 2014. The original pharmaceutical manufacturer is GlaxoSmithKline. It was approved for marketing in my country in 2018. In addition, Suimeikai from the Indian Emcure Pharmaceutical Company is also very popular among patients because of its relatively low price. Emcure was founded in 1983 with the goal of creating a healthcare company to serve a broad range of healthcare needs.

Instructions for Suimeike from Emcure Pharmaceuticals Company of India

Generic name: Doptabalamid tablets

Product name: Suimeikai

All names: Suimei Kai, Dolutegra Abalamid Tablets, TRIUMEQ, Inbec

Indications: Suitable for the treatment of adults and adolescents over 12 years old (weight at least 40kg) infected with human immunodeficiency virus (HIV).

Usage and Dosage: There are no specific requirements for the taking time of Suimeikan. For adults and teenagers, the recommended dosage of Suimeikan is one tablet each time, once a day. It is best to take it at the same time every day to ensure the continuous effect of the medicine.

If a dose is missed, judge whether to take it again based on the time until the next dose. If you miss a dose but there are more than 4 hours before the next dose, you should take Suimei Kai as soon as possible. If the next dose is less than 4 hours away, the patient should not take the missed dose and wait until the next dose to take it as originally planned.

Adverse reactions: The most common adverse reactions associated with Trimax are nausea (12%), insomnia (7%), dizziness (6%) and headache (6%).

Contraindications: Contraindicated in patients with known hypersensitivity to dolutegravir, abacavir, and lamivudine or any excipients. Concomitant use with dofetilide and pisicanide is prohibited.

The above is the instruction manual of Emcure Pharmaceutical Company of India. I hope it will be helpful to you.

Recommended related hot articles: /newsDetail/87260.html